WE investigated the effect of nitric oxide (NO) on N-methyl-D-aspartat
e (NMDA)-induced changes in levels of dopamine (DA) and its metabolite
in the striatum using in vivo microdialysis. Local administration of
1 mM NMDA into the striatum significantly augmented DA release in the
striatum. Simultaneous administration of 5 mM NG-nitro-L-arginine meth
yl ester (-NAME), a NO synthase inhibitor, into the striatum significa
ntly potentiated NMDA-induced DA release. This effect of L-NAME was co
mpletely reversed in the presence of 50 mM L-arginine (L-Arg). Adminis
tration of 1 mM NMDA significantly decreased the levels of dihydroxyph
enylacetic acid (DOPAC) and homovanillic acid (HVA). This effect of NM
DA was not affected by concurrent administration of L-NAME. This study
provides in vivo evidence for the involvement of NO in NMDA-induced D
A release.